Hear how George Goldsmith and Ekaterina Malievskaia from COMPASS Pathways are working to bring innovation psychedelic drug applications for depression. Learn what what this means for patients, regulators and trials.
Panel Conversation Featuring:
- George Goldsmith Co-Founder and Executive Chairman of COMPASS Pathways
- Dr Ekaterina Malievskaia, Research and Development at COMPASS
- Jane Metcalf, Founder of Neo.Life
- Dr Amir Kalali, Chief Curator of CNS Summit
This was recorded on the main stage at the 2019 CNS Summit which was held in Boca Raton, Florida. To learn more about CNS Summit and read full bios on each speaker, head to CNSSummit.org.
Follow us on Twitter (@cnssummit).
Hear and subscribe to all the episodes in this series on Health Podcast Network.
Podden och tillhörande omslagsbild på den här sidan tillhör CNS Summit. Innehållet i podden är skapat av CNS Summit och inte av, eller tillsammans med, Poddtoppen.
